21st Century Oncology, Greenville, NC 27834-3764, USA.
Photodiagnosis Photodyn Ther. 2010 Jun;7(2):61-75. doi: 10.1016/j.pdpdt.2010.02.001. Epub 2010 Apr 21.
A myriad of naturally occurring and synthetic structures are capable of transferring the energy of light. Few, however, allow for this energy transfer to enable a type II photochemical reaction which, as currently practiced, is a fundamental component of photodynamic therapy. Even fewer of these agents, aptly termed photosensitizers, have found success in the treatment of patients. This review will focus on the oncologic photosensitizers that have come to clinical trial with outcomes published in peer reviewed journals. Based on a clinical orientation the qualities of successful photosensitizers will be examined, how current drugs fare and potential future options explored.
许多天然和合成的结构都能够传递光的能量。然而,很少有结构能够允许这种能量转移来实现 II 型光化学反应,而这种光化学反应目前是光动力疗法的基本组成部分。在这些被恰当地称为光敏剂的试剂中,更少的试剂在治疗患者方面取得了成功。本综述将重点介绍已进入临床试验并在同行评议期刊上发表结果的肿瘤光敏剂。基于临床方向,将检查成功的光敏剂的特性、现有药物的效果和潜在的未来选择。